DS
AGN

David Shaw’s Allergan plc AGN Stock Holding History

David Shaw’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-461,899
Closed -$81.8M – 4383
2020
Q1 		$81.8M Sell
461,899
-162,102
-26% -$30.5M 0.13% 173
2019
Q4 		$119M Sell
624,001
-425,949
-41% -$76.8M 0.14% 170
2019
Q3 		$177M Sell
1,049,950
-121,396
-10% -$19.8M 0.22% 81
2019
Q2 		$196M Buy
1,171,346
+235,849
+25% +$32.7M 0.24% 64
2019
Q1 		$137M Buy
935,497
+513,424
+122% +$74.4M 0.18% 122
2018
Q4 		$56.4M Buy
422,073
+5,127
+1% +$840K 0.08% 312
2018
Q3 		$79.4M Buy
416,946
+282,456
+210% +$51.9M 0.1% 261
2018
Q2 		$22.4M Sell
134,490
-108,087
-45% -$17.4M 0.03% 663
2018
Q1 		$40.8M Sell
242,577
-974,273
-80% -$163M 0.06% 409
2017
Q4 		$199M Buy
1,216,850
+1,075,677
+762% +$193M 0.27% 64
2017
Q3 		$28.9M Sell
141,173
-8,554
-6% -$1.99M 0.04% 478
2017
Q2 		$36.4M Buy
149,727
+56,085
+60% +$13.2M 0.06% 384
2017
Q1 		$22.4M Sell
93,642
-1,009
-1% -$235K 0.04% 523
2016
Q4 		$19.9M Buy
94,651
+15,717
+20% +$3.26M 0.03% 623
2016
Q3 		$18.2M Sell
78,934
-323,076
-80% -$78.9M 0.03% 615
2016
Q2 		$92.9M Sell
402,010
-1,888,467
-82% -$435M 0.17% 129
2016
Q1 		$614M Buy
2,290,477
+1,385,489
+153% +$397M 1.1% 3
2015
Q4 		$283M Sell
904,988
-110,192
-11% -$32.8M 0.42% 34
2015
Q3 		$276M Buy
1,015,180
+426,161
+72% +$131M 0.41% 34
2015
Q2 		$179M Sell
589,019
-66,598
-10% -$19.9M 0.27% 63
2015
Q1 		$195M Buy
655,617
+483,184
+280% +$138M 0.3% 59
2014
Q4 		$44.4M Buy
172,433
+17,339
+11% +$4.33M 0.06% 393
2014
Q3 		$37.4M Sell
155,094
-124,240
-44% -$27.8M 0.05% 427
2014
Q2 		$62.3M Sell
279,334
-25,236
-8% -$5.23M 0.08% 263
2014
Q1 		$62.7M Buy
304,570
+295,855
+3,395% +$58.6M 0.09% 242
2013
Q4 		$1.46M Sell
8,715
-92,456
-91% -$14.5M ﹤0.01% 2820
2013
Q3 		$14.6M Buy
+101,171
New +$13.5M 0.02% 756

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $5.64B AUM 18.33% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

David Shaw's AGN Position: Q2 2020 in Review

David Shaw sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 461,899 shares — an estimated $81.8M sold.

David Shaw first reported a position in AGN in Q3 2013 and held it in 27 quarters. The position peaked at $614M in Q1 2016. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • David Shaw reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • David Shaw sold 461,899 Allergan plc shares in Q2 2020, an estimated $81.8M.
  • David Shaw first reported a position in Allergan plc in Q3 2013 and held it in 27 quarters.
  • David Shaw's Allergan plc position peaked at $614M in Q1 2016.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on D.E. Shaw & Co's 13F filing for Q2 2020, filed 14 Aug 2020.